Home/Filings/4/0001209191-22-004681
4//SEC Filing

WORLAND STEPHEN T 4

Accession 0001209191-22-004681

CIK 0001828522other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 8:04 PM ET

Size

5.7 KB

Accession

0001209191-22-004681

Insider Transaction Report

Form 4
Period: 2022-01-20
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-20+520,674520,674 total
    Exercise: $6.65Exp: 2032-01-19Common Stock (520,674 underlying)
Footnotes (1)
  • [F1]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 20, 2022 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1
  • filerCIK 0001283307

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:04 PM ET
Size
5.7 KB